Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q42781881
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000210.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q42781881
|
024
|
|
|
‡a
0000-0001-5585-7739
‡2
orcid
|
024
|
|
|
‡a
8941674500
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q42781881
|
100
|
0 |
|
‡a
Kyung-yul Lee
‡9
sl
|
400
|
0 |
|
‡a
Kyung-yul Lee
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Kyung-yul Lee
‡c
wetenschapper
‡9
nl
|
400
|
0 |
|
‡a
Kyung-yul Lee
‡c
investigador/a
‡9
es
|
400
|
0 |
|
‡a
Kyung-yul Lee
‡c
investigador
‡9
ast
|
670
|
|
|
‡a
Author's A case of acute disseminated encephalomyelitis associated with hepatitis C virus infection
|
670
|
|
|
‡a
Author's A case of reversible postpartum cytotoxic edema in preeclampsia.
|
670
|
|
|
‡a
Author's A Protocol-Based Decision for Choosing a Proper Surgical Treatment Option for Carotid Artery Stenosis
|
670
|
|
|
‡a
Author's Antiplatelet effect of clopidogrel can be reduced by calcium-channel blockers.
|
670
|
|
|
‡a
Author's Atrial fibrillation in patients with first-ever stroke: Incidence trends and antithrombotic therapy before the event
|
670
|
|
|
‡a
Author's Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9.
|
670
|
|
|
‡a
Author's Brachial plexopathy caused by subclavian artery aneurysm in Behçet's disease
|
670
|
|
|
‡a
Author's Cerebral Venous Sinus Thrombosis Associated with Dutasteride Use
|
670
|
|
|
‡a
Author's Cilostazol decreases cerebral arterial pulsatility in patients with mild white matter hyperintensities: subgroup analysis from the Effect of Cilostazol in Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler
|
670
|
|
|
‡a
Author's Cilostazol decreases cerebral arterial pulsatility in patients with mild white matter hyperintensities: subgroup analysis from the Effect of Cilostazol in Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler (ECLIPse) study
|
670
|
|
|
‡a
Author's Classic risk factors for atherosclerosis are not major determinants for location of extracranial or intracranial cerebral atherosclerosis.
|
670
|
|
|
‡a
Author's Claude's syndrome associated with neurocysticercosis.
|
670
|
|
|
‡a
Author's Clopidogrel preventive effect based on cytochrome P450 2C19 genotype in ischaemic stroke: protocol for multicentre observational study
|
670
|
|
|
‡a
Author's Comparison of Long Term Prognosis between Carotid Endarterectomy versus Stenting; A Korean Population-Based Study Using National Insurance Data
|
670
|
|
|
‡a
Author's Delayed cerebral infarction due to stent folding deformation following carotid artery stenting
|
670
|
|
|
‡a
Author's Distal hyperintense vessels on FLAIR: an MRI marker for collateral circulation in acute stroke?
|
670
|
|
|
‡a
Author's Effect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in Korea
|
670
|
|
|
‡a
Author's Endovascular treatment of iatrogenic intracranial pseudoaneurysm following stent angioplasty
|
670
|
|
|
‡a
Author's Frequent Premature Atrial Contractions as a Poor Prognostic Factor in Cryptogenic Stroke Patients with Concomitant Non-Sustained Atrial Tachycardia
|
670
|
|
|
‡a
Author's Hashimoto Encephalopathy Mimicking Acute Ischemic Stroke: Perfusion-Weighted Magnetic Resonance Imaging
|
670
|
|
|
‡a
Author's Immediate reocclusion following a successful thrombolysis in acute stroke: a pilot study.
|
670
|
|
|
‡a
Author's Improvement of sudden bilateral hearing loss after vertebral artery stenting
|
670
|
|
|
‡a
Author's Increase in Plasma Matrix Metalloproteinase-9 in Acute Stroke Patients With Thrombolysis Failure
|
670
|
|
|
‡a
Author's Increase in rat plasma antioxidant activity after E. coli lipopolysaccharide administration.
|
670
|
|
|
‡a
Author's Isolated bilateral abducens nerve palsy due to carotid cavernous dural arteriovenous fistula
|
670
|
|
|
‡a
Author's Ivy Sign on Fluid-Attenuated Inversion Recovery Images in Moyamoya Disease: Correlation with Clinical Severity and Old Brain Lesions
|
670
|
|
|
‡a
Author's Localization of Claude's syndrome
|
670
|
|
|
‡a
Author's Magnetic resonance tractography in a patient with alexia without agraphia
|
670
|
|
|
‡a
Author's Mirror pattern of cerebral artery atherosclerosis in patients with ischaemic stroke
|
670
|
|
|
‡a
Author's Prevalence and Characteristics of Unruptured Cerebral Aneurysms in Ischemic Stroke Patients
|
670
|
|
|
‡a
Author's Process improvement to enhance existing stroke team activity toward more timely thrombolytic treatment
|
670
|
|
|
‡a
Author's Protocol for the comparison of triflusal and clopidogrel in secondary prevention of stroke based on cytochrome P450 2C19 genotyping (MASETRO study): A multicenter, randomized, open-label, parallel-group trial.
|
670
|
|
|
‡a
Author's Recanalization of acute intracranial artery occlusion using temporary endovascular bypass technique.
|
670
|
|
|
‡a
Author's Renal Subcapsular Hematoma after Intravenous Thrombolysis in a Patient with Acute Cerebral Infarction.
|
670
|
|
|
‡a
Author's Self-expanding stent for recanalization of acute embolic or dissecting intracranial artery occlusion.
|
670
|
|
|
‡a
Author's Serotonin transporter gene polymorphism and migraine in the Korean population
|
670
|
|
|
‡a
Author's Serum and cerebrospinal fluid neuron-specific enolase for diagnosis of tuberculous meningitis
|
670
|
|
|
‡a
Author's Serum soluble E-selectin levels in Kawasaki disease
|
670
|
|
|
‡a
Author's Short-term Cessation of Dabigatran Causes a Paradoxical Prothrombotic State
|
670
|
|
|
‡a
Author's Significance of hyperintense arteries on Gd-enhanced 3D T1W black-blood imaging in acute stroke
|
670
|
|
|
‡a
Author's Simple microwire and microcatheter mechanical thrombolysis with adjuvant intraarterial urokinase for treatment of hyperacute ischemic stroke patients.
|
670
|
|
|
‡a
Author's Tc-99m ECD SPECT and FDG PET in partial status epilepticus resulting from cerebral sparganosis
|
670
|
|
|
‡a
Author's Temporary stenting and retrieval of the self-expandable, intracranial stent in acute middle cerebral artery occlusion
|
670
|
|
|
‡a
Author's The influence of anti-platelet resistance on the development of cerebral ischemic lesion after carotid artery stenting
|
670
|
|
|
‡a
Author's Various Clinical Manifestations in a Heterozygous Fabry Disease Family: From Asymptomatic to Acute Ischemic Stroke with Intracranial Cerebral Artery Stenosis
|
670
|
|
|
‡a
Author's Vestibular imbalance associated with a lesion in the nucleus prepositus hypoglossi area
|
670
|
|
|
‡a
Author's Yonsei Stroke Registry. Analysis of 1,000 patients with acute cerebral infarctions.
|
909
|
|
|
‡a
(orcid) 0000000155857739
‡9
1
|
909
|
|
|
‡a
(scopus) 8941674500
‡9
1
|
919
|
|
|
‡a
cilostazoldecreasescerebralarterialpulsatilityinpatientswithmildwhitematterhyperintensitiessubgroupanalysisfromtheeffectofcilostazolinacutelacunarinfarctionbasedonpulsatilityindexoftranscranialdopplereclipsestudy
‡A
Cilostazol decreases cerebral arterial pulsatility in patients with mild white matter hyperintensities: subgroup analysis from the Effect of Cilostazol in Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler (ECLIPse) study
‡9
1
|
919
|
|
|
‡a
bloodbrainbarrierdisruptioninhumansisindependentlyassociatedwithincreasedmatrixmetalloproteinase9
‡A
Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9.
‡9
1
|
919
|
|
|
‡a
brachialplexopathycausedbysubclavianarteryaneurysminbehcetsdisease
‡A
Brachial plexopathy caused by subclavian artery aneurysm in Behçet's disease
‡9
1
|
919
|
|
|
‡a
cerebralvenoussinusthrombosisassociatedwithdutasterideuse
‡A
Cerebral Venous Sinus Thrombosis Associated with Dutasteride Use
‡9
1
|
919
|
|
|
‡a
cilostazoldecreasescerebralarterialpulsatilityinpatientswithmildwhitematterhyperintensitiessubgroupanalysisfromtheeffectofcilostazolinacutelacunarinfarctionbasedonpulsatilityindexoftranscranialdoppler
‡A
Cilostazol decreases cerebral arterial pulsatility in patients with mild white matter hyperintensities: subgroup analysis from the Effect of Cilostazol in Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler
‡9
1
|
919
|
|
|
‡a
yonseistrokeregistryanalysisof1000patientswithacutecerebralinfarctions
‡A
Yonsei Stroke Registry. Analysis of 1,000 patients with acute cerebral infarctions.
‡9
1
|
919
|
|
|
‡a
vestibularimbalanceassociatedwithalesioninthenucleusprepositushypoglossiarea
‡A
Vestibular imbalance associated with a lesion in the nucleus prepositus hypoglossi area
‡9
1
|
919
|
|
|
‡a
variousclinicalmanifestationsinaheterozygousfabrydiseasefamilyfromasymptomatictoacuteischemicstrokewithintracranialcerebralarterystenosis
‡A
Various Clinical Manifestations in a Heterozygous Fabry Disease Family: From Asymptomatic to Acute Ischemic Stroke with Intracranial Cerebral Artery Stenosis
‡9
1
|
919
|
|
|
‡a
influenceofantiplateletresistanceonthedevelopmentofcerebralischemiclesionaftercarotidarterystenting
‡A
The influence of anti-platelet resistance on the development of cerebral ischemic lesion after carotid artery stenting
‡9
1
|
919
|
|
|
‡a
temporarystentingandretrievaloftheselfexpandableintracranialstentinacutemiddlecerebralarteryocclusion
‡A
Temporary stenting and retrieval of the self-expandable, intracranial stent in acute middle cerebral artery occlusion
‡9
1
|
919
|
|
|
‡a
tc99mecdspectandfdgpetinpartialstatusepilepticusresultingfromcerebralsparganosis
‡A
Tc-99m ECD SPECT and FDG PET in partial status epilepticus resulting from cerebral sparganosis
‡9
1
|
919
|
|
|
‡a
simplemicrowireandmicrocathetermechanicalthrombolysiswithadjuvantintraarterialurokinasefortreatmentofhyperacuteischemicstrokepatients
‡A
Simple microwire and microcatheter mechanical thrombolysis with adjuvant intraarterial urokinase for treatment of hyperacute ischemic stroke patients.
‡9
1
|
919
|
|
|
‡a
significanceofhyperintensearteriesongdenhanced3dt1wblackbloodimaginginacutestroke
‡A
Significance of hyperintense arteries on Gd-enhanced 3D T1W black-blood imaging in acute stroke
‡9
1
|
919
|
|
|
‡a
shorttermcessationofdabigatrancausesaparadoxicalprothromboticstate
‡A
Short-term Cessation of Dabigatran Causes a Paradoxical Prothrombotic State
‡9
1
|
919
|
|
|
‡a
serumsolubleeselectinlevelsinkawasakidisease
‡A
Serum soluble E-selectin levels in Kawasaki disease
‡9
1
|
919
|
|
|
‡a
serumandcerebrospinalfluidneuronspecificenolasefordiagnosisoftuberculousmeningitis
‡A
Serum and cerebrospinal fluid neuron-specific enolase for diagnosis of tuberculous meningitis
‡9
1
|
919
|
|
|
‡a
serotonintransportergenepolymorphismandmigraineinthekoreanpopulation
‡A
Serotonin transporter gene polymorphism and migraine in the Korean population
‡9
1
|
919
|
|
|
‡a
selfexpandingstentforrecanalizationofacuteembolicordissectingintracranialarteryocclusion
‡A
Self-expanding stent for recanalization of acute embolic or dissecting intracranial artery occlusion.
‡9
1
|
919
|
|
|
‡a
renalsubcapsularhematomaafterintravenousthrombolysisinapatientwithacutecerebralinfarction
‡A
Renal Subcapsular Hematoma after Intravenous Thrombolysis in a Patient with Acute Cerebral Infarction.
‡9
1
|
919
|
|
|
‡a
recanalizationofacuteintracranialarteryocclusionusingtemporaryendovascularbypasstechnique
‡A
Recanalization of acute intracranial artery occlusion using temporary endovascular bypass technique.
‡9
1
|
919
|
|
|
‡a
protocolforthecomparisonoftriflusalandclopidogrelinsecondarypreventionofstrokebasedoncytochromep4502c19genotypingmasetrostudyamulticenterrandomizedopenlabelparallelgrouptrial
‡A
Protocol for the comparison of triflusal and clopidogrel in secondary prevention of stroke based on cytochrome P450 2C19 genotyping (MASETRO study): A multicenter, randomized, open-label, parallel-group trial.
‡9
1
|
919
|
|
|
‡a
processimprovementtoenhanceexistingstroketeamactivitytowardmoretimelythrombolytictreatment
‡A
Process improvement to enhance existing stroke team activity toward more timely thrombolytic treatment
‡9
1
|
919
|
|
|
‡a
prevalenceandcharacteristicsofunrupturedcerebralaneurysmsinischemicstrokepatients
‡A
Prevalence and Characteristics of Unruptured Cerebral Aneurysms in Ischemic Stroke Patients
‡9
1
|
919
|
|
|
‡a
mirrorpatternofcerebralarteryatherosclerosisinpatientswithischaemicstroke
‡A
Mirror pattern of cerebral artery atherosclerosis in patients with ischaemic stroke
‡9
1
|
919
|
|
|
‡a
magneticresonancetractographyinapatientwithalexiawithoutagraphia
‡A
Magnetic resonance tractography in a patient with alexia without agraphia
‡9
1
|
919
|
|
|
‡a
localizationofclaudessyndrome
‡A
Localization of Claude's syndrome
‡9
1
|
919
|
|
|
‡a
ivysignonfluidattenuatedinversionrecoveryimagesinmoyamoyadiseasecorrelationwithclinicalseverityandoldbrainlesions
‡A
Ivy Sign on Fluid-Attenuated Inversion Recovery Images in Moyamoya Disease: Correlation with Clinical Severity and Old Brain Lesions
‡9
1
|
919
|
|
|
‡a
isolatedbilateralabducensnervepalsyduetocarotidcavernousduralarteriovenousfistula
‡A
Isolated bilateral abducens nerve palsy due to carotid cavernous dural arteriovenous fistula
‡9
1
|
919
|
|
|
‡a
increaseinratplasmaantioxidantactivityafterecolilipopolysaccharideadministration
‡A
Increase in rat plasma antioxidant activity after E. coli lipopolysaccharide administration.
‡9
1
|
919
|
|
|
‡a
increaseinplasmamatrixmetalloproteinase9inacutestrokepatientswiththrombolysisfailure
‡A
Increase in Plasma Matrix Metalloproteinase-9 in Acute Stroke Patients With Thrombolysis Failure
‡9
1
|
919
|
|
|
‡a
improvementofsuddenbilateralhearinglossaftervertebralarterystenting
‡A
Improvement of sudden bilateral hearing loss after vertebral artery stenting
‡9
1
|
919
|
|
|
‡a
immediatereocclusionfollowingasuccessfulthrombolysisinacutestrokeapilotstudy
‡A
Immediate reocclusion following a successful thrombolysis in acute stroke: a pilot study.
‡9
1
|
919
|
|
|
‡a
hashimotoencephalopathymimickingacuteischemicstrokeperfusionweightedmagneticresonanceimaging
‡A
Hashimoto Encephalopathy Mimicking Acute Ischemic Stroke: Perfusion-Weighted Magnetic Resonance Imaging
‡9
1
|
919
|
|
|
‡a
frequentprematureatrialcontractionsasapoorprognosticfactorincryptogenicstrokepatientswithconcomitantnonsustainedatrialtachycardia
‡A
Frequent Premature Atrial Contractions as a Poor Prognostic Factor in Cryptogenic Stroke Patients with Concomitant Non-Sustained Atrial Tachycardia
‡9
1
|
919
|
|
|
‡a
endovasculartreatmentofiatrogenicintracranialpseudoaneurysmfollowingstentangioplasty
‡A
Endovascular treatment of iatrogenic intracranial pseudoaneurysm following stent angioplasty
‡9
1
|
919
|
|
|
‡a
caseofacutedisseminatedencephalomyelitisassociatedwithhepatitis100virusinfection
‡A
A case of acute disseminated encephalomyelitis associated with hepatitis C virus infection
‡9
1
|
919
|
|
|
‡a
effectofstatinsonfastingglucoseinnondiabeticindividualsnationwidepopulationbasedhealthexaminationinkorea
‡A
Effect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in Korea
‡9
1
|
919
|
|
|
‡a
distalhyperintensevesselsonflairanmrimarkerforcollateralcirculationinacutestroke
‡A
Distal hyperintense vessels on FLAIR: an MRI marker for collateral circulation in acute stroke?
‡9
1
|
919
|
|
|
‡a
caseofreversiblepostpartumcytotoxicedemainpreeclampsia
‡A
A case of reversible postpartum cytotoxic edema in preeclampsia.
‡9
1
|
919
|
|
|
‡a
protocolbaseddecisionforchoosingapropersurgicaltreatmentoptionforcarotidarterystenosis
‡A
A Protocol-Based Decision for Choosing a Proper Surgical Treatment Option for Carotid Artery Stenosis
‡9
1
|
919
|
|
|
‡a
delayedcerebralinfarctionduetostentfoldingdeformationfollowingcarotidarterystenting
‡A
Delayed cerebral infarction due to stent folding deformation following carotid artery stenting
‡9
1
|
919
|
|
|
‡a
comparisonoflongtermprognosisbetweencarotidendarterectomyversusstentingakoreanpopulationbasedstudyusingnationalinsurancedata
‡A
Comparison of Long Term Prognosis between Carotid Endarterectomy versus Stenting; A Korean Population-Based Study Using National Insurance Data
‡9
1
|
919
|
|
|
‡a
antiplateleteffectofclopidogrelcanbereducedbycalciumchannelblockers
‡A
Antiplatelet effect of clopidogrel can be reduced by calcium-channel blockers.
‡9
1
|
919
|
|
|
‡a
atrialfibrillationinpatientswith1everstrokeincidencetrendsandantithrombotictherapybeforetheevent
‡A
Atrial fibrillation in patients with first-ever stroke: Incidence trends and antithrombotic therapy before the event
‡9
1
|
919
|
|
|
‡a
clopidogrelpreventiveeffectbasedoncytochromep4502c19genotypeinischaemicstrokeprotocolformulticentreobservationalstudy
‡A
Clopidogrel preventive effect based on cytochrome P450 2C19 genotype in ischaemic stroke: protocol for multicentre observational study
‡9
1
|
919
|
|
|
‡a
claudessyndromeassociatedwithneurocysticercosis
‡A
Claude's syndrome associated with neurocysticercosis.
‡9
1
|
919
|
|
|
‡a
classicriskfactorsforatherosclerosisarenotmajordeterminantsforlocationofextracranialorintracranialcerebralatherosclerosis
‡A
Classic risk factors for atherosclerosis are not major determinants for location of extracranial or intracranial cerebral atherosclerosis.
‡9
1
|
996
|
|
|
‡2
NII|DA01866350
|
996
|
|
|
‡2
NTA|151594368
|
996
|
|
|
‡2
ISNI|0000000047238068
|
996
|
|
|
‡2
ISNI|0000000513203592
|
996
|
|
|
‡2
ISNI|0000000460122261
|
996
|
|
|
‡2
ISNI|0000000505438340
|
996
|
|
|
‡2
NTA|317299948
|
996
|
|
|
‡2
ISNI|0000000475185353
|
996
|
|
|
‡2
LC|n 2023056720
|
996
|
|
|
‡2
ISNI|0000000492163500
|
996
|
|
|
‡2
ISNI|000000047379960X
|
996
|
|
|
‡2
DNB|1172990948
|
996
|
|
|
‡2
ISNI|0000000480164282
|
996
|
|
|
‡2
DNB|143756885
|
996
|
|
|
‡2
LC|n 2013001202
|
996
|
|
|
‡2
NTA|242616968
|
996
|
|
|
‡2
LC|n 88035846
|
996
|
|
|
‡2
ISNI|0000000474734779
|
996
|
|
|
‡2
BNF|18103345
|
996
|
|
|
‡2
ISNI|0000000465099275
|
996
|
|
|
‡2
DNB|1157435114
|
996
|
|
|
‡2
ISNI|0000000478563823
|
996
|
|
|
‡2
ISNI|0000000508983045
|
996
|
|
|
‡2
ISNI|0000000494043334
|
996
|
|
|
‡2
ISNI|0000000480243319
|
996
|
|
|
‡2
ISNI|0000000473710740
|
996
|
|
|
‡2
NII|DA08442115
|
996
|
|
|
‡2
ISNI|0000000479051432
|
996
|
|
|
‡2
ISNI|0000000463650991
|
996
|
|
|
‡2
ISNI|0000000467895160
|
996
|
|
|
‡2
ISNI|0000000513597747
|
996
|
|
|
‡2
ISNI|0000000483465566
|
996
|
|
|
‡2
ISNI|0000000464594450
|
996
|
|
|
‡2
ISNI|0000000508951860
|
996
|
|
|
‡2
ISNI|0000000467663490
|
996
|
|
|
‡2
ISNI|0000000480106269
|
996
|
|
|
‡2
ISNI|0000000467656960
|
996
|
|
|
‡2
ISNI|0000000464347185
|
996
|
|
|
‡2
LC|n 2006181258
|
996
|
|
|
‡2
ISNI|0000000035964986
|
996
|
|
|
‡2
ISNI|0000000468269030
|
996
|
|
|
‡2
SUDOC|233517049
|
996
|
|
|
‡2
ISNI|0000000040112155
|
996
|
|
|
‡2
NSK|000735821
|
996
|
|
|
‡2
ISNI|0000000473789348
|
996
|
|
|
‡2
ISNI|0000000491716783
|
996
|
|
|
‡2
ISNI|0000000473791165
|
996
|
|
|
‡2
ISNI|000000046469526X
|
996
|
|
|
‡2
ISNI|0000000463646589
|
996
|
|
|
‡2
DNB|1122436858
|
996
|
|
|
‡2
ISNI|0000000505506796
|
996
|
|
|
‡2
ISNI|0000000464354350
|
996
|
|
|
‡2
ISNI|0000000465098280
|
996
|
|
|
‡2
ISNI|0000000480106410
|
996
|
|
|
‡2
LC|n 89134852
|
996
|
|
|
‡2
NDL|01042149
|
996
|
|
|
‡2
SUDOC|225329379
|
996
|
|
|
‡2
ISNI|0000000031210706
|
996
|
|
|
‡2
BNF|15016039
|
996
|
|
|
‡2
ISNI|0000000508981912
|
996
|
|
|
‡2
ISNI|0000000467719132
|
996
|
|
|
‡2
ISNI|0000000494059969
|
996
|
|
|
‡2
ISNI|0000000513319747
|
996
|
|
|
‡2
ISNI|0000000509589162
|
996
|
|
|
‡2
ISNI|0000000494052206
|
996
|
|
|
‡2
ISNI|0000000479082896
|
996
|
|
|
‡2
ISNI|0000000468052093
|
996
|
|
|
‡2
DNB|1026258685
|
996
|
|
|
‡2
ISNI|0000000468513451
|
996
|
|
|
‡2
ISNI|000000048010604X
|
996
|
|
|
‡2
CAOONL|ncf10699854
|
996
|
|
|
‡2
ISNI|0000000490070036
|
996
|
|
|
‡2
ISNI|0000000476778505
|
996
|
|
|
‡2
ISNI|0000000464675007
|
996
|
|
|
‡2
BNF|15599241
|
996
|
|
|
‡2
ISNI|0000000465114156
|
996
|
|
|
‡2
ISNI|0000000478779675
|
996
|
|
|
‡2
ISNI|0000000018000018
|
996
|
|
|
‡2
ISNI|0000000505076116
|
996
|
|
|
‡2
ISNI|0000000464936000
|
996
|
|
|
‡2
ISNI|0000000473777339
|
996
|
|
|
‡2
ISNI|0000000461083209
|
996
|
|
|
‡2
DNB|1232680923
|
996
|
|
|
‡2
ISNI|0000000476676867
|
996
|
|
|
‡2
ISNI|0000000493238930
|
996
|
|
|
‡2
ISNI|0000000492263587
|
996
|
|
|
‡2
ISNI|0000000464867893
|
996
|
|
|
‡2
ISNI|0000000504840573
|
996
|
|
|
‡2
ISNI|0000000464873839
|
996
|
|
|
‡2
RERO|A026832891
|
996
|
|
|
‡2
DNB|120542897
|
996
|
|
|
‡2
LC|n 2010038748
|
996
|
|
|
‡2
ISNI|0000000502767448
|
996
|
|
|
‡2
ISNI|0000000514876713
|
996
|
|
|
‡2
ISNI|0000000483600051
|
996
|
|
|
‡2
ISNI|0000000504997191
|
996
|
|
|
‡2
ISNI|0000000492268599
|
996
|
|
|
‡2
BIBSYS|90380079
|
996
|
|
|
‡2
ISNI|000000051333623X
|
996
|
|
|
‡2
LC|no 94003723
|
996
|
|
|
‡2
ISNI|0000000505276417
|
996
|
|
|
‡2
ISNI|0000000443169623
|
996
|
|
|
‡2
ISNI|0000000473803816
|
996
|
|
|
‡2
ISNI|0000000054952331
|
996
|
|
|
‡2
ISNI|0000000474118626
|
996
|
|
|
‡2
LC|n 83038662
|
996
|
|
|
‡2
BLBNB|000679107
|
996
|
|
|
‡2
ISNI|0000000493195045
|
996
|
|
|
‡2
ISNI|0000000463265540
|
996
|
|
|
‡2
LC|nr 97006754
|
996
|
|
|
‡2
ISNI|0000000464185542
|
996
|
|
|
‡2
ISNI|0000000087571156
|
996
|
|
|
‡2
ISNI|0000000505508089
|
996
|
|
|
‡2
ISNI|0000000463312132
|
996
|
|
|
‡2
ISNI|0000000476779831
|
996
|
|
|
‡2
ISNI|0000000476873916
|
996
|
|
|
‡2
ISNI|000000049250175X
|
996
|
|
|
‡2
LC|no 97028371
|
996
|
|
|
‡2
BIBSYS|4090530
|
996
|
|
|
‡2
ISNI|0000000479077843
|
996
|
|
|
‡2
ISNI|0000000480164151
|
996
|
|
|
‡2
NKC|xx0301128
|
996
|
|
|
‡2
DNB|1147043914
|
996
|
|
|
‡2
LC|n 91129070
|
996
|
|
|
‡2
NTA|400908026
|
996
|
|
|
‡2
ISNI|0000000479100951
|
996
|
|
|
‡2
ISNI|0000000464871657
|
996
|
|
|
‡2
LC|no2004099406
|
996
|
|
|
‡2
ISNI|0000000042588464
|
996
|
|
|
‡2
ISNI|0000000479344593
|
996
|
|
|
‡2
ISNI|000000047907452X
|
996
|
|
|
‡2
ISNI|0000000513364302
|
996
|
|
|
‡2
ISNI|0000000388293102
|
996
|
|
|
‡2
ISNI|0000000000407207
|
996
|
|
|
‡2
ISNI|0000000509012080
|
996
|
|
|
‡2
ISNI|0000000514842716
|
996
|
|
|
‡2
NYNYRILM|120785
|
996
|
|
|
‡2
LC|n 2022005663
|
996
|
|
|
‡2
ISNI|0000000505747979
|
996
|
|
|
‡2
LC|n 2021068651
|
996
|
|
|
‡2
NDL|01123437
|
996
|
|
|
‡2
ISNI|0000000465101179
|
996
|
|
|
‡2
ISNI|0000000493147473
|
996
|
|
|
‡2
LC|n 2008007714
|
996
|
|
|
‡2
CAOONL|ncf11894857
|
996
|
|
|
‡2
ISNI|0000000514812664
|
996
|
|
|
‡2
SUDOC|078637880
|
996
|
|
|
‡2
ISNI|0000000483544774
|
996
|
|
|
‡2
PTBNP|276619
|
996
|
|
|
‡2
ISNI|0000000460414205
|
996
|
|
|
‡2
ISNI|0000000464458088
|
996
|
|
|
‡2
ISNI|0000000464350448
|
996
|
|
|
‡2
ISNI|0000000508948741
|
996
|
|
|
‡2
ISNI|0000000492847726
|
996
|
|
|
‡2
DNB|14324728X
|
996
|
|
|
‡2
DNB|1083293494
|
996
|
|
|
‡2
ISNI|0000000509608028
|
996
|
|
|
‡2
ISNI|0000000476783080
|
996
|
|
|
‡2
ISNI|0000000461080104
|
996
|
|
|
‡2
ISNI|0000000054668293
|
996
|
|
|
‡2
ISNI|0000000474919335
|
996
|
|
|
‡2
ISNI|0000000466758631
|
996
|
|
|
‡2
ISNI|0000000492457875
|
996
|
|
|
‡2
ISNI|0000000513349460
|
996
|
|
|
‡2
ISNI|000000046479660X
|
996
|
|
|
‡2
ISNI|0000000468435537
|
996
|
|
|
‡2
DNB|1011643618
|
996
|
|
|
‡2
BIBSYS|90880138
|
996
|
|
|
‡2
DNB|135336953
|
996
|
|
|
‡2
LC|n 88013972
|
996
|
|
|
‡2
ISNI|0000000473938497
|
996
|
|
|
‡2
ISNI|0000000460847967
|
996
|
|
|
‡2
ISNI|000000046776534X
|
996
|
|
|
‡2
ISNI|000000046829413X
|
996
|
|
|
‡2
ISNI|0000000480164100
|
996
|
|
|
‡2
ISNI|0000000459464651
|
996
|
|
|
‡2
DNB|1019016809
|
996
|
|
|
‡2
ISNI|0000000508982958
|
996
|
|
|
‡2
ISNI|0000000476781456
|
996
|
|
|
‡2
ISNI|0000000516693590
|
996
|
|
|
‡2
ISNI|0000000512501467
|
996
|
|
|
‡2
ISNI|0000000512703798
|
996
|
|
|
‡2
ISNI|0000000475938642
|
996
|
|
|
‡2
ISNI|0000000465144136
|
996
|
|
|
‡2
ISNI|0000000513503341
|
996
|
|
|
‡2
ISNI|0000000491717161
|
996
|
|
|
‡2
ISNI|0000000460983678
|
996
|
|
|
‡2
ISNI|0000000513177427
|
996
|
|
|
‡2
ISNI|0000000505504299
|
996
|
|
|
‡2
ISNI|0000000505817498
|
996
|
|
|
‡2
DNB|1057731889
|
996
|
|
|
‡2
NUKAT|n 96301642
|
996
|
|
|
‡2
SUDOC|172464188
|
996
|
|
|
‡2
ISNI|0000000505974450
|
996
|
|
|
‡2
ISNI|0000000508982237
|
996
|
|
|
‡2
NTA|363800271
|
996
|
|
|
‡2
J9U|987007369013005171
|
996
|
|
|
‡2
DNB|124348548
|
996
|
|
|
‡2
ISNI|0000000493263116
|
996
|
|
|
‡2
ISNI|0000000476779305
|
996
|
|
|
‡2
ISNI|0000000509058396
|
996
|
|
|
‡2
ISNI|0000000464303385
|
996
|
|
|
‡2
ISNI|0000000464361454
|
996
|
|
|
‡2
DNB|13370100X
|
996
|
|
|
‡2
ISNI|000000048032467X
|
996
|
|
|
‡2
ISNI|000000047957660X
|
996
|
|
|
‡2
ISNI|0000000071455871
|
996
|
|
|
‡2
ISNI|0000000505881844
|
996
|
|
|
‡2
ISNI|0000000372339065
|
996
|
|
|
‡2
ISNI|0000000479026456
|
996
|
|
|
‡2
JPG|500245935
|
996
|
|
|
‡2
ISNI|000000047413583X
|
996
|
|
|
‡2
ISNI|0000000477792608
|
996
|
|
|
‡2
BNF|12474814
|
996
|
|
|
‡2
DNB|1309164185
|
996
|
|
|
‡2
ISNI|0000000463316694
|
996
|
|
|
‡2
ISNI|0000000049441713
|
996
|
|
|
‡2
ISNI|0000000467848997
|
996
|
|
|
‡2
ISNI|0000000504389743
|
996
|
|
|
‡2
ISNI|0000000492163658
|
996
|
|
|
‡2
ISNI|0000000468294033
|
996
|
|
|
‡2
DE633|pe50045840
|
996
|
|
|
‡2
ISNI|0000000491683483
|
996
|
|
|
‡2
ISNI|0000000464380081
|
996
|
|
|
‡2
ISNI|0000000114592738
|
996
|
|
|
‡2
NII|DA1709770X
|
996
|
|
|
‡2
ISNI|0000000493230672
|
996
|
|
|
‡2
ISNI|0000000478813239
|
996
|
|
|
‡2
ISNI|0000000463349074
|
996
|
|
|
‡2
ISNI|0000000374442074
|
996
|
|
|
‡2
ISNI|0000000490069510
|
996
|
|
|
‡2
ISNI|0000000505509778
|
996
|
|
|
‡2
ISNI|0000000491717065
|
996
|
|
|
‡2
ISNI|0000000464829563
|
996
|
|
|
‡2
ISNI|000000046492005X
|
996
|
|
|
‡2
JPG|500693169
|
996
|
|
|
‡2
ISNI|0000000472481923
|
996
|
|
|
‡2
ISNI|0000000505535570
|
996
|
|
|
‡2
ISNI|0000000497987541
|
996
|
|
|
‡2
ISNI|0000000514843436
|
996
|
|
|
‡2
ISNI|0000000483449240
|
996
|
|
|
‡2
ISNI|0000000464853547
|
996
|
|
|
‡2
LC|n 2015001036
|
996
|
|
|
‡2
DNB|1059249693
|
996
|
|
|
‡2
LC|n 2021025731
|
996
|
|
|
‡2
NTA|069059896
|
996
|
|
|
‡2
ISNI|0000000464688203
|
996
|
|
|
‡2
ISNI|0000000024877537
|
996
|
|
|
‡2
SUDOC|033942048
|
996
|
|
|
‡2
SUDOC|245176349
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|